Matt is a seasoned intellectual property litigator and cannabis attorney with extensive trial and post-grant experience involving a variety of technologies. He helps clients protect their businesses, innovations, and practices by having an intimate understanding of their technology and business goals, implementing creative and thoughtful dispute resolution strategies, and developing sophisticated intellectual property tactics.
Matt is a registered patent attorney with a background in molecular and cellar biology and an advanced degree in medical cannabis sciences. On the litigation front, Matt advocates for clients in patent litigation and post-grant proceedings, including ITC litigation and disputes arising under the Hatch-Waxman Act. Regarding his cannabis practice, Matt earned his M.S. in Medical Cannabis Sciences and Therapeutics, developing a heightened understanding of the scientific and clinical uses of the cannabis plant to augment his legal perspectives on cannabis-related issues and counsel cannabis clients regarding the same.
Clients also value Matt's prior experience as patent counsel in the oncology division of one of the world's leading biopharmaceutical companies, where he oversaw and developed the patent estates of oncology pipeline biologics and was lead IP counsel on numerous intellectual property transactions—including IP discovery, tech transfer, and licensing agreements.
Matt has extensive experience developing global patent prosecution strategies, drafting legal opinions and intellectual property agreements, and performing patentability and freedom-to-operate analyses. He has extensive experience with numerous and diverse technologies, including but not limited to:
- Pharmaceuticals & biologics
- Chemotherapeutics (both large and small molecule)
- Cannabis (including cannabinoid-centric compositions and extraction and purification of cannabinoids)
- Antibodies and derivatives thereof
- Cell-based therapeutics (including CAR-T cells)
- Host cells, genetic vectors and vaccines
- Recombinants (including plant-expressed, recombinant proteins)
- Medical devices
- Air conditioning systems
- Diesel engines
- Polymers
- Inflatable devices (e.g., air mattresses)
Outside of his legal practice, Matt is an adjunct faculty member at the University of Maryland School of Pharmacy, where he developed and teaches a course on state and federal cannabis laws and policies.